A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group

[Rinshō ketsueki] The Japanese journal of clinical hematology

Volumn 40, Issue 10, 1999, Pages 1058-1067

  Chou, T ^a   Ishiguro, T ^a   Imajo, K ^a   Kawano, F ^a   Gondo, H ^a   Kasai, M ^a   Masuda, M ^a   Koike, M ^a   Shimazaki, C ^a   Hara, M ^a   Shinagawa, K ^a   Ogawa, M ^a   Takaku, F ^a   Harada, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0033203394     PISSN: 04851439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)